Arthrosamid: A New Approach to Treating Patellofemoral Osteoarthritis
Arthrosamid® is an innovative intra-articular polyacrylamide hydrogel injection offering effective pain relief and improved mobility for patellofemoral osteoarthritis (PF-OA). Clinical studies demonstrate its safety and superior long-term benefits over hyaluronic acid, especially in patients under 70 with moderate osteoarthritis. This single injection restores joint lubrication and cushioning, reducing friction and enhancing knee function with minimal side effects. Arthrosamid presents a convenient and promising alternative to traditional treatments, supporting rehabilitation and long-term joint health. Ongoing research aims to optimize patient selection and assess durability, establishing Arthrosamid as a valuable therapy for managing PF-OA.
